Pharmaceutical composition for preventing and/or treating asthma, its preparation method and application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of medicine, can solve problems such as unsatisfactory therapeutic effect, drug poisoning, and low curative effect
Active Publication Date: 2013-09-04
天津中医药大学第二附属医院
View PDF2 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0027] To sum up, the currently used western medicines and treatments have more or less defects, such as low curative effect, drug dependence, large side effects, hig...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0056] The technical solution of the present invention will be clearly and completely described in the form of specific embodiments below. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
[0057] One, the preparation embodiment of pharmaceutical composition of the present invention
[0058] The experimental materials and methods used in the following examples are conventional materials and methods unless otherwise specified.
preparation Embodiment 1
[0059] Preparation Example 1: Preparation according to the pharmaceutical composition of the present invention
[0060] The pharmaceutical composition thus prepared is referred to as the drug A of the present invention.
[0061] Take 8kg of roasted ephedra, 10kg of almonds, 20kg of mulberry bark, 16kg of scutellaria baicalensis, 10kg of cicada slough, 10kg of silkworm, 20kg of earthworm, 10kg of ginkgo, 10kg of Peucedanum, 10kg of shegan, 20kg of aster .
preparation Embodiment 2
[0062] Preparation Example 2: Preparation according to the pharmaceutical composition of the present invention
[0063] The pharmaceutical composition thus prepared is referred to as the drug B of the present invention.
[0064] Take 6kg of roasted ephedra, 12kg of almonds, 22kg of mulberry bark, 18kg of scutellaria baicalensis, 12kg of cicada slough, 12kg of silkworm, 22kg of earthworm, 12kg of ginkgo, 12kg of Peucedanum, 12kg of shegan, 22kg of aster .
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for preventing and/or treating asthma and a preparation method and an application thereof. The invention relates to a traditional Chinese medicine composition, a pharmaceutical composition and its preparation method, application of the traditional Chinese medicine composition and the pharmaceutical composition. According to the invention, the preparation raw materials of the pharmaceutical composition effective constituents are or contain: by weight, 6 to 10 parts of Main ephedra, 8 to 12 parts of almond, 18 to 22 parts of Cortex Mori, 14 to 18 parts of Radix scutellariae, 8 to 12 parts of periostracan cicadae, 8 to 12 parts of Bombyx batryticatus, 18 to 22 parts of earthworm, 8 to 12 parts of ginkgo seed, 8 to 12 parts of Radix Peucedani, 8 to 12 parts of Belamcanda chinensis, 18 to 22 parts of Aster tataricus, 8 to 12 parts of Pinellia ternate and 4 to 8 parts of Glycyrrhiza uralensis.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for preventing and / or treating asthma, its preparation method and application. Background technique [0002] Bronchial asthma (abbreviation: asthma) is a kind of common disease, frequently-occurring disease. At present, there are about 300 million asthmatics in the world, and about 30 million asthmatics in China. Asthma is an important disease that affects people's physical and mental health. If it is not treated in time and not standardized, it may be fatal. [0003] The common symptoms of asthma patients are paroxysmal wheezing, shortness of breath, chest tightness, or coughing. A small number of patients may also have chest pain as the main manifestation. These symptoms are often exposed to irritating gases such as smoke, perfume, paint, dust, pets, and pollen. or after the onset of allergens, night and / or early morning symptoms are also likely ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more